出版社 | MarketsandMarkets |
出版年月 | 2025年1月 |
Sleep Software Market – Global Forecast To 2030
The global Sleep Software market is projected to reach USD 1,569.2 Million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period.
世界の睡眠ソフトウェア市場は、予測期間中に10.1%のCAGRで、2024年の8億7,890万米ドルから2030年までに15億6,920万米ドルに達すると予測されています。
The growth in the sleep software market is driven by the shift towards preventive health since individuals and health systems are putting more emphasis on proactive wellness approaches rather than reacting to treatments. Sleep software can play a major role in such a shift by allowing users to track their sleep, spot early sleep issues, and develop healthier habits for long-term wellness. As awareness grows about the link between sleep quality and chronic conditions such as obesity, heart disease, and mental health disorders, consumers are increasingly adopting tools that help address potential issues before they become serious.
個人や医療システムは治療に反応するよりも予防的な健康アプローチに重点を置いているため、睡眠ソフトウェア市場の成長は予防的健康への移行によって推進されています。睡眠ソフトウェアは、ユーザーが自分の睡眠を追跡し、初期の睡眠の問題を発見し、長期的な健康のためのより健康的な習慣を身につけることを可能にすることで、このような変化において重要な役割を果たすことができます。睡眠の質と肥満、心臓病、精神的健康障害などの慢性疾患との関連性についての意識が高まるにつれ、潜在的な問題が深刻になる前に対処できるツールを消費者が導入するケースが増えています。

List of Companies Profiled in the Report
- Koninklijke Philips N.V. (Netherlands)
- Cadwell Industries Inc. (US)
- COMPUMEDICS LIMITED (Australia)
- Neurovirtual. (US)
- NIHON KOHDEN CORPORATION (Japan)
- Nox Medical (Iceland)
- Natus Medical Incorporated (ARCHIMED) (US)
- RXNT (US)
- Resmed (US)
- Cleveland Medical Devices Inc. (US)
- SOMNOmedics AG (Germany)
- CIDELEC (France)
- Calm (US)
- Sleep Cycle (Sweden)
- Headspace Inc. (US)
- Löwenstein Medical SE & Co. KG (Germany)
- CamNtech Ltd (United Kingdom)
- Fisher & Paykel Healthcare Limited. (New Zealand)
- BioSerenity (France)
- VYAIRE MEDICAL INC (US)
- Inspire Medical Systems, Inc. (US)
- HoneyNaps (South Korea)
- Sleep Reset (US)
- SleepImage. (US)
- BigHealth (US)
- Bodymatter, Inc. (US)
- Neybox Digital Ltd. (US)
- Consumer Sleep Solutions LLC. (US)
This report provides insights on:
- Analysis of key drivers (growing incidence of sleep disorders, increasing adoption of telehealth and mhealth, increasing emphasis on corporate wellness programs, growing awareness regarding sleep apnea and wellness improvement, favorable reimbursement and financial aid for sleep apnea devices and therapies), restraints (use of alternative therapies and medications for sleep disorders, data security and privacy concerns, resistance from tradition healthcare providers), opportunities (adoption of advanced technologies, integration with wearable devices, personalized sleep solutions, mental health and wellness integration), challenges (lack of clinical validation for many solutions, regulatory compliance complexities, growing concerns about data privacy and security.) are factors contributing the growth of the sleep software market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the sleep software market.
- Market Development: Comprehensive information on the lucrative emerging markets, type, offering, function, indications, deployment model, end user, and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the sleep software market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global sleep software market such as Koninklijke Philips N.V. (Netherlands), Resmed (US), Calm (US), Headspace Inc. (US), Inspire Medical Systems, Inc. (US).